Infant Formula Manufacturers Refuse To Remove GMO And New Research Now Links Formula To Chronic Disease

Natasha Longo, Prevent Disease
Waking Times

Nestle and Mead Johnson Nutrition recently dismissed calls to remove genetically-modified organisms (GMO) from their infant formula products in the US and now evidence is coming forth on long-term risks related to infant formulations. Epidemiological research has indicated a relationship between infant formula feeding and increased risk of chronic diseases later in life including obesity, type-2 diabetes, and cardiovascular disease. Researchers stated that the comprehensive metabolic implications of formula vs breast-feeding play a role in long-term health risks.

Nestle and Mead Johnson Nutrition recently dismissed calls to remove genetically-modified organisms (GMO) from their infant formula products in the US — citing the approved use of GMOs by several national and global regulatory bodies.

According to anti-GMO campaign group, GMO Inside, these companies “likely” use GMO ingredients such as soy, corn and sugar in their popular infant formula products.

In the letter, the campaign group urged Nestle USA’s Paul Bulcke, Abbott Laboratories’ Miles White, and Mead Johnson Nutrition’s R Kasper Jakobsen to “take a proactive stand and announce a phase out of all GMOs in your infant formulas in 2013.”

“Similac, Enfamil, and Gerber Good Start — which combined account for more than 90% of all infant formula sales in the US — are exposing American and Canadian babies to potentially grave health risks by using genetically modified ingredients,” said a statement accompanying the letter.